Literature DB >> 29278762

Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.

Yunju Kim1, Sung Hun Kim2, Hye Won Lee3, Byung Joo Song4, Bong Joo Kang5, Ahwon Lee3, Yoonho Nam5.   

Abstract

PURPOSE: To determine the diagnostic performance of intravoxel incoherent motion (IVIM) diffusion-weighted (DW) magnetic resonance imaging (MRI) parameters in predicting response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
MATERIALS AND METHODS: Forty-six patients with stage II or III breast cancer underwent MRI including DW imaging with 10 b values before and after 2cycles of NAC. Apparent diffusion coefficient (ADC) and IVIM parameters (D, D*, and f) were obtained using histogram analysis derived from whole-tumor volumes. After surgery, imaging parameters were compared with histopathologic responses using the Miller-Payne grading system.
RESULTS: Before NAC, Dmean, D50, and D75 were higher in good responders than in minor responders (P≤0.043). After NAC, ADCmean, ADC50, ADC75, Dmean, D25, D50, and D75 were higher in good responders (P≤0.037). Skewness of ADC and D were lower in good responders after NAC (P≤0.005). Most histogram metrics of posttreatment ADC and D had similar AUC values with reasonable accuracy for prediction of good response (AUC≥0.7, P<0.05).
CONCLUSION: D and ADC are useful for the prediction of response to NAC in breast cancer patients. Additional information is obtained by application of the IVIM model in DW imaging analysis and histogram analysis using whole-tumor volume data.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Diffusion; Magnetic resonance imaging; Neoadjuvant therapy

Mesh:

Year:  2017        PMID: 29278762     DOI: 10.1016/j.mri.2017.12.018

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

Review 1.  Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.

Authors:  Xianshu Kong; Qian Zhang; Xuemei Wu; Tianning Zou; Jiajun Duan; Shujie Song; Jianyun Nie; Chu Tao; Mi Tang; Maohua Wang; Jieya Zou; Yu Xie; Zhenhui Li; Zhen Li
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 2.  Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.

Authors:  Huan Wang; Xiaoyun Mao
Journal:  Drug Des Devel Ther       Date:  2020-06-18       Impact factor: 4.162

Review 3.  Factors affecting the value of diffusion-weighted imaging for identifying breast cancer patients with pathological complete response on neoadjuvant systemic therapy: a systematic review.

Authors:  Kay J J van der Hoogt; Robert J Schipper; Gonneke A Winter-Warnars; Leon C Ter Beek; Claudette E Loo; Ritse M Mann; Regina G H Beets-Tan
Journal:  Insights Imaging       Date:  2021-12-18

4.  Using the apparent diffusion coefficient histogram analysis to predict response to neoadjuvant chemotherapy in patients with breast cancer: comparison among three region of interest selection methods.

Authors:  Xiaochuan Geng; Dandan Zhang; Shiteng Suo; Jie Chen; Fang Cheng; Kebei Zhang; Qing Zhang; Lan Li; Yang Lu; Jia Hua; Zhiguo Zhuang
Journal:  Ann Transl Med       Date:  2022-03

Review 5.  Diffusion Breast MRI: Current Standard and Emerging Techniques.

Authors:  Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

6.  Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.

Authors:  Shiteng Suo; Yan Yin; Xiaochuan Geng; Dandan Zhang; Jia Hua; Fang Cheng; Jie Chen; Zhiguo Zhuang; Mengqiu Cao; Jianrong Xu
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

7.  Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study.

Authors:  Kurt Li; Archana Machireddy; Alina Tudorica; Brendan Moloney; Karen Y Oh; Neda Jafarian; Savannah C Partridge; Xin Li; Wei Huang
Journal:  Tomography       Date:  2020-06

8.  Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.

Authors:  Alexey Surov; Andreas Wienke; Hans Jonas Meyer
Journal:  Breast       Date:  2020-06-26       Impact factor: 4.380

9.  Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy.

Authors:  Dominic Carlin; Alexander Weller; Gem Kramer; Yan Liu; John C Waterton; Arturo Chiti; Martina Sollini; A Joop de Langen; Mary E R O'Brien; Maria Urbanowicz; Bart Km Jacobs; Nandita deSouza
Journal:  BJR Open       Date:  2019-07-20

Review 10.  Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role.

Authors:  Julia Camps-Herrero
Journal:  BJR Open       Date:  2019-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.